Dotz Nano Limited Stocks

A$ 0.03Last Updated 31.03.2026

Issuer Rating

2/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

A$ 15.66M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
A$ 0.03
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Dotz Nano Limited engages in the development and marketing of carbon-based materials use in tracing, anti-counterfeiting, and product-liability solutions. It provides ValiDotz, BioDotz, Fluorensic, and InSpec solutions for various applications, such as anti-counterfeiting, brand and reputation protection, oil and gas industry, liquids tagging, lubricants, polymers tagging, and bio imaging. The company sells its products through distributors in North America, Europe, Japan, China, and Australia. It has scientific collaborations and partnerships with various academic institutes; and a collaboration agreement with Theracell Labs Ltd for the co-development, supply, and licensing of disposable bioprocessing consumables. Dotz Nano Limited is headquartered in Kfar Saba, Israel.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks